QR Code

Use of Remdesivir in Patients with SARS-CoV-2 Pneumonia in a Real-Life Setting during the Second and Third COVID-19 Epidemic Waves

In this retrospective comparative study, we evaluated the effectiveness of remdesivir (RDSV) in patients with SARS-CoV-2 pneumonia. Individuals hospitalized between March 2020 and August 2022 at S.M. Goretti Hospital, Latina, with a positive test for SARS-CoV-2 and, concomitantly, pneumonia, were in...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Raffaella Marocco, Cosmo Del Borgo, Eeva Tortellini, Silvia Garattini, Anna Carraro, Daniela Di Trento, Andrea Gasperin, Alessandra Grimaldi, Tiziana Tieghi, Valeria Belvisi, Blerta Kertusha, Mariasilvia Guardiani, Paola Zuccalà, Danilo Alunni Fegatelli, Alessandra Spagnoli, Miriam Lichtner, LATINA COVID-group
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2023-04-01
Rangatū:Viruses
Ngā marau:
remdesivir
SARS-CoV-2
antiviral therapy
COVID-19
real-life study
Urunga tuihono:https://www.mdpi.com/1999-4915/15/4/947
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite